Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
ConditionBladder Urothelial Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
Prior abdominal imaging
Disqualifiers
History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)
Trial population
Patients undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Observational1 intervention
Trial outcomes
Primary outcomes
1
Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage
The radiology-assessed tumor stage from the ultrasound (US) and the core needle biopsy-assessed tumor stage will be compared with the final pathologic tumor stage.
Time frame
Baseline (after completion of bladder surgery)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov